NASDAQ · Biotechnology

XBiotech Inc. (XBIT) Stock

$2.29 +4.09% NASDAQ: XBIT Healthcare

Valuation

MetricValue
Price$2.29
Market Cap$69.82M
P/E Ratio-1.49
P/B Ratio0.52
P/S Ratio0.00
EPS (TTM)$-1.49
52-Week High$3.44
52-Week Low$2.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-31.62%
ROA-33.77%
ROCE-37.01%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio15.88

Annual Financials (USD)

Metric20212022202320242025
Revenue$18.0M$4.0M$0$0$0
Operating Profit$-25.0M$-34.0M$-38.0M$-42.0M$-56.0M
Net Profit$-17.0M$-33.0M$-25.0M$-39.0M$-46.0M
EPS$-0.58$-1.08$-0.81$-1.26$-1.49
Op Margin-136.4%-860.1%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$275.0M$246.0M$227.0M$199.0M$150.0M
Total Liabilities$6.0M$6.0M$8.0M$17.0M$10.0M
Cash$237.0M$157.0M$200.0M$173.0M$126.0M
Borrowings$0$0$0$10.0M$0

Latest News

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis GlobeNewswire · Jun 15, 2026 XBiotech: Q1 Earnings Snapshot Associated Press · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$69.0M$-15.0M$-19.0M$-31.0M$-40.0M
Investing Cash Flow$-7.0M$-64.0M$61.0M$-3.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$-80.0M$43.0M$-27.0M$-47.0M
Free Cash Flow$66.0M$-15.0M$-19.0M$-32.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA1.02
FCF Yield-60.88%
Quick Ratio33.15
Interest Coverage0.00
Return 1Y-16.00%
Return 3Y-55.58%
Return 5Y-85.85%

Ownership

Insiders Held24.33%
Institutions Held6.81%
Institutions Float Held9.01%
Institutional HolderSharesReport Date
Blackrock Inc.293,1042026-03-31
Geode Capital Management, LLC231,0202026-03-31
Vanguard Capital Management LLC200,9712026-03-31
RBF Capital, LLC198,5012026-03-31
Morgan Stanley165,5542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACETAdicet Bio, Inc. $5.61 -2.26% -0.57 $52.44M 0.00%
ACRVAcrivon Therapeutics, Inc. $1.91 +2.14% -1.12 $81.75M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
CRVOCervoMed Inc. $3.22 -1.83% -0.94 $29.81M 0.00%
FBIOFortress Biotech, Inc. $2.13 +2.15% 0.64 $70.92M 0.00%

About XBiotech Inc.

XBiotech Inc. is led by CEO Sushma Shivaswamy, employs 92 people, headquartered in US, publicly traded since 2015.

XBiotech Inc. (XBIT) stock trades at $2.29 with a market capitalization of $69.82M. The stock is valued at a price-to-earnings (P/E) ratio of -1.49, price-to-book of 0.52, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.09 and $3.44, and currently trades 33.4% below its 52-week high.

On profitability, XBiotech Inc. generates a return on equity (ROE) of -31.62%, return on capital employed of -37.01%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides